IMAGING

Jeong Min LEE

SITE

Eur Radiol. 2022;32:46-55. LI-RADS v2018: how to appropriately use ancillary features in category adjustment from intermediate probability of malignancy (LR-3) to probably HCC (LR-4) on gadoxetic acid-enhanced MRI. Jeon SK, Joo I, Bae JS, Park SJ, Lee JM. PubMed

Eur Radiol. 2021;31:5615-5628. Consensus report from the 9th International Forum for Liver Magnetic Resonance Imaging: applications of gadoxetic acid-enhanced imaging. Koh DM, Ba-Ssalamah A, Brancatelli G, Fananapazir G, Fiel MI, Goshima S, Ju SH, Kartalis N, Kudo M, Lee JM, Murakami T, Seidensticker M, Sirlin CB, Tan CH, Wang J, Yoon JH, Zeng M, Zhou J, Taouli B. PubMed

Eur Radiol. 2020;30:2861-2870. LI-RADS treatment response categorization on gadoxetic acid-enhanced MRI: diagnostic performance compared to mRECIST and added value of ancillary features. Kim SW, Joo I, Kim HC, Ahn SJ, Kang HJ, Jeon SK, Lee JM. PubMed

Eur Radiol. 2020;30:1624-1633. Hepatobiliary phase hypointense nodule without arterial phase hyperenhancement: are they at risk of HCC recurrence after ablation or surgery? A systematic review and meta-analysis. Kim TH, Woo S, Han S, Suh CH, Lee DH, Lee JM. PubMed

Eur Radiol. 2020;30:370-382. Consensus report from the 8th International Forum for liver Magnetic Resonance Imaging. Zech CJ, Ba-Ssalamah A, Berg T, Chandarana H, Chau GY, Grazioli L, Kim MJ, Lee JM, Merkle EM, Murakami T, Ricke J, B Sirlin C, Song B, Taouli B, Yoshimitsu K, Koh DM. PubMed

Korean J Radiol. 2019;20:1019-1041. Atypical appearance of hepatocellular carcinoma and its mimickers: How to solve challenging cases using Gadoxetic Acid-enhanced liver Magnetic Resonance Imaging. Kim JH, Joo I, Lee JM. PubMed

Korean J Radiol. 2019;20:438-448. High acceleration three-dimensional T1-weighted dual echo Dixon hepatobiliary phase imaging using compressed sensing-sensitivity encoding: Comparison of image quality and solid lesion detectability with the standard T1-weighted sequence. Nam JG, Lee JM, Lee SM, Kang HJ, Lee ES, Hur BY, Yoon JH, Kim E, Doneva M. PubMed

Eur Radiol. 2019;29:3122-3131. Non-hypervascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced MR can help determine the treatment method for HCC. Lee DH, Lee JM, Yu MH, Hur BY, Yi NJ, Lee KW, Suh KS, Yoon JH, Kim YJ, Lee JH, Yu SJ, Han JK. PubMed

Radiology. 2019;290:125-133. Quantitative assessment of liver function by using Gadoxetic Acid-enhanced MRI: hepatocyte uptake ratio. Yoon JH, Lee JM, Kang HJ, Ahn SJ, Yang H, Kim E, Okuaki T, Han JK. PubMed

Eur Radiol. 2019;29:1724-1732. Retrospective validation of a new diagnostic criterion for hepatocellular carcinoma on gadoxetic acid-enhanced MRI: can hypointensity on the hepatobiliary phase be used as an alternative to washout with the aid of ancillary features? Joo I, Lee JM, Lee DH, Jeon JH, Han JK. PubMed

J Magn Reson Imaging. 2018;49:574-587. Added Value of sequentially performed gadoxetic acid-enhanced liver MRI for the diagnosis of small (10-19 mm) or atypical hepatic observations at contrast-enhanced CT: A prospective comparison. Yoon JH, Lee JM, Lee YJ, Lee KB, Han JK. PubMed

Invest Radiol. 2018;53:52-6. Evaluation of transient motion during Gadoxetic acid-enhanced Multiphasic liver magnetic resonance imaging using free-breathing golden-angle radial sparse parallel magnetic resonance imaging. Yoon JH, Lee JM, Yu MH, Hur BY, Grimm R, Block KT, Chandarana H, Kiefer B, Son Y. PubMed

Korean J Radiol. 2017;18:682-690. T2* mapping from multi-echo Dixon sequence on Gadoxetic acid-enhanced Magnetic Resonance Imaging for the hepatic fat quantification: Can it be used for hepatic function assessment? Yoo H, Lee JM, Yoon JH, Kang HJ, Lee SM, Yang HK, Han JK. PubMed

Radiology. 2017;285:134-146. Diagnostic performance of Gadoxetic acid-enhanced liver MR imaging versus Multidetector CT in the detection of dysplastic nodules and early hepatocellular carcinoma. Kim BR, Lee JM, Lee DH, Yoon JH, Hur BY, Suh KS, Yi NJ, Lee KB, Han JK. PubMed

Invest Radiol. 2017;52:596-604. Clinical feasibility of free-breathing dynamic T1-weighted imaging with Gadoxetic acid-enhanced liver Magnetic Resonance Imaging using a combination of variable density sampling and compressed sensing. Yoon JH, Yu MH, Chang W, Park JY, Nickel MD, Son Y, Kiefer B, Lee JM. PubMed

Korean J Radiol. 2017;18:427-443. Diagnosis of hepatocellular carcinoma with Gadoxetic acid-enhanced MRI: 2016 Consensus recommendations of the Korean Society of Abdominal Radiology. 26 collaborators. PubMed

J Magn Reson Imaging. 2017; in press. Additional values of high-resolution gadoxetic acid-enhanced MR cholangiography for evaluating the biliary anatomy of living liver donors: Comparison with T2 -weighted MR cholangiography and conventional gadoxetic acid-enhanced MR cholangiography. Kang HJ, Lee JM, Yoon JH, Joo I, Chang W, Suh KS, Lee KW, Yi NJ, Han JK. PubMed

Radiology. 2017;282:408-417. Quantitative liver function analysis: volumetric T1 mapping with fast multisection B1 inhomogeneity correction in hepatocyte-specific contrast-enhanced liver MR imaging. Yoon JH, Lee JM, Kim E, Okuaki T, Han JK. PubMed

J Hepatol. 2016;65:1155-1162. Pre-treatment estimation of future remnant liver function using gadoxetic acid MRI in patients with HCC. Yoon JH, Choi JI, Jeong YY, Schenk A, Chen L, Laue H, Kim SY, Lee JM. PubMed

J Magn Reson Imaging. 2017;45:731-740. Liver imaging reporting and data system v2014 categorization of hepatocellular carcinoma on gadoxetic acid-enhanced MRI: Comparison with multiphasic multidetector computed tomography. Joo I, Lee JM, Lee DH, Ahn SJ, Lee ES, Han JK. PubMed

Korean J Radiol. 2016;17:522-32. Triple arterial phase MR Imaging with Gadoxetic acid using a combination of contrast enhanced time robust angiography, keyhole, and viewsharing techniques and two-dimensional parallel imaging in comparison with conventional single arterial phase. Yoon JH, Lee JM, Yu MH, Kim EJ, Han JK. PubMed

Radiology. 2016;280:782-92. Colorectal cancer liver metastases: diagnostic performance and prognostic value of PET/MR Imaging. Lee DH, Lee JM, Hur BY, Joo I, Yi NJ, Suh KS, Kang KW, Han JK. PubMed

J Magn Reson Imaging. 2016;44:1330-1338. Diagnostic accuracy of liver imaging reporting and data system (LI-RADS) v2014 for intrahepatic mass-forming cholangiocarcinomas in patients with chronic liver disease on gadoxetic acid-enhanced MRI. Joo I, Lee JM, Lee SM, Lee JS, Park JY, Han JK. PubMed

Liver Cancer. 2016;5:67-87. Recent advances in the imaging diagnosis of hepatocellular carcinoma: value of Gadoxetic acid-enhanced MRI. Joo I, Lee JM. PubMed

Radiology. 2016;279:773-83. Portal vein thrombosis in patients with hepatocellular carcinoma: diagnostic accuracy of Gadoxetic acid-enhanced MR Imaging. Kim JH, Lee JM, Yoon JH, Lee DH, Lee KB, Han JK, Choi BI. PubMed

Eur Radiol. 2016;26:1808-17. Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on Gadoxetic acid-enhanced liver MR imaging. Kim R, Lee JM, Shin CI, Lee ES, Yoon JH, Joo I, Kim SH, Hwang I, Han JK, Choi BI. PubMed

Eur Radiol. 2016;26:1775-82. Quantitative assessment of hepatic function: modified look-locker inversion recovery (MOLLI) sequence for T1 mapping on Gd-EOB-DTPA-enhanced liver MR imaging. Yoon JH, Lee JM, Paek M, Han JK, Choi BI. PubMed

Eur Radiol. 2016;26:674-82. Consensus report from the 7th International Forum for Liver Magnetic Resonance Imaging. Merkle EM, Zech CJ, Bartolozzi C, Bashir MR, Ba-Ssalamah A, Huppertz A, Lee JM, Ricke J, Sakamoto M, Sirlin CB, Ye SL, Zeng M. PubMed

Eur Radiol. 2015 ;25:2428-36. Gadoxetic acid-enhanced MRI and diffusion-weighted imaging for the detection of colorectal liver metastases after neoadjuvant chemotherapy. Yu MH, Lee JM, Hur BY, Kim TY, Jeong SY, Yi NJ, Suh KS, Han JK, Choi BI. PubMed

Eur Radiol. 2015;25:2859-68. Noninvasive diagnosis of hepatocellular carcinoma on gadoxetic acid-enhanced MRI: can hypointensity on the hepatobiliary phase be used as an alternative to washout? Joo I, Lee JM, Lee DH, Jeon JH, Han JK, Choi. PubMed

Radiology. 2015;275:97-109. Hepatocellular carcinoma: diagnostic performance of multidetector CT and MR imaging-a systematic review and meta-analysis. Lee YJ, Lee JM, Lee JS, Lee HY, Park BH, Kim YH, Han JK, Choi BI. PubMed

J Hepatol. 2015;62:1122-30. Non-hypervascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced MRI: risk of HCC recurrence after radiofrequency ablation. Lee DH, Lee JM, Lee JY, Kim SH, Kim JH, Yoon JH, Kim YJ, Lee JH, Yu SJ, Han JK, Choi BI. PubMed

Acta Radiol. 2015;56:1454-62. Fat-suppressed, three-dimensional T1-weighted imaging using high-acceleration parallel acquisition and a dual-echo Dixon technique for gadoxetic acid-enhanced liver MRI at 3 T. Yoon JH, Lee JM, Yu MH, Kim EJ, Han JK, Choi BI. PubMed

Dig Dis. 2014;32:678-89. Non-hypervascular hypointense nodules ≥1 cm on the hepatobiliary phase of gadoxetic acid-enhanced magnetic resonance imaging in cirrhotic livers. Yoon JH, Lee JM, Yang HK, Lee KB, Jang JJ, Han JK, Choi BI. PubMed

Abdom Imaging. 2015;40:843-51. Prediction of microvascular invasion of hepatocellular carcinoma using gadoxetic acid-enhanced MR and (18)F-FDG PET/CT. Ahn SY, Lee JM, Joo I, Lee ES, Lee SJ, Cheon GJ, Han JK, Choi BI. PubMed

Abdom Imaging. 2015;40:531-41. Differentiation of lipid poor angiomyolipoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging. Kim R, Lee JM, Joo I, Lee DH, Woo S, Han JK, Choi BI. PubMed

Radiology. 2015;274:149-60. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings. Lee DH, Lee JM, Baek JH, Shin CI, Han JK, Choi BI. PubMed

Abdom Imaging. 2015;40:278-88. Navigated three-dimensional T1-weighted gradient-echo sequence for gadoxetic acid liver magnetic resonance imaging in patients with limited breath-holding capacity. Yoon JH, Lee JM, Lee ES, Baek J, Lee S, Iwadate Y, Han JK, Choi BI. PubMed

J Comput Assist Tomogr. 2014 ;38:360-6. High spatial resolution, respiratory-gated, t1-weighted magnetic resonance imaging of the liver and the biliary tract during the hepatobiliary phase of gadoxetic Acid-enhanced magnetic resonance imaging. Lee ES, Lee JM, Yu MH, Shin CI, Woo HS, Joo I, Stemmer A, Han JK, Choi BI. PubMed

Korean J Radiol. 2013;14:894-904. MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent gadoxetic acid. Lee KH, Lee JM, Park JH, Kim JH, Park HS, Yu MH, Yoon JH, Han JK, Choi BI. PubMed

Invest Radiol. 2013;48:607-13. Comparison of magnetic resonance elastography and gadoxetate disodium-enhanced magnetic resonance imaging for the evaluation of hepatic fibrosis. Choi YR, Lee JM, Yoon JH, Han JK, Choi BI. PubMed

Radiology. 2013;267:776-86. Hepatocellular carcinoma: imaging patterns on gadoxetic acid-enhanced MR Images and their value as an imaging biomarker. Choi JW, Lee JM, Kim SJ, Yoon JH, Baek JH, Han JK, Choi BI. PubMed

J Magn Reson Imaging. 2013;38:138-47. Gadoxetic acid-enhanced MRI with MR cholangiography for the preoperative evaluation of bile duct cancer. Sun HY, Lee JM, Park HS, Yoon JH, Baek JH, Han JK, Choi BI. PubMed

Semin Oncol. 2012;39:399-409. Diagnosis of hepatocellular carci-noma: newer radiological tools. Lee JM, Yoon JH, Kim KW. PubMed

Radiology. 2012;264:751-60. Intrahepatic mass-forming cholangio-carcinoma: enhancement patterns on gadoxetic acid-enhanced MR images. Kang Y, Lee JM, Kim SH, Han JK, Choi BI. PubMed

Liver Cancer. 2012;1:22-40. Recent Advances in CT and MR Imaging for Evaluation of Hepatocellular Carcinoma. Lee JM Yoon JH, Joo I, Woo HS. PubMed

Korean J Radiol. 2011;12:403-15. doi: Consensus report of the 4th International Forum for Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid Magnetic Resonance Imaging. Lee JM, Zech CJ, Bolondi L, Jonas E, Kim MJ, Matsui O, Merkle EM, Sakamoto M, Choi BI. PubMed

AJR Am J Roentgenol. 2011;197:399-405. Gadoxetate disodium-enhanced hepatobiliary phase MRI of hepatocellular carcinoma: correlation with histological characteristics. Choi JY, Kim MJ, Park YN, Lee JM, Yoo SK, Rha SY, Seok JY. PubMed

J Magn Reson Imaging. 2011;33:149-59. Gadoxetic acid disodium-enhanced magnetic resonance imaging for biliary and vascular evaluations in preoperative living liver donors: comparison with gadobenate dimeglumine-enhanced MRI. Lee MS, Lee JY, Kim SH, Park HS, Kim SH, Lee JM, Han JK, Choi BI. PubMed